0001051514-23-000011.txt : 20230227 0001051514-23-000011.hdr.sgml : 20230227 20230227162020 ACCESSION NUMBER: 0001051514-23-000011 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230227 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230227 DATE AS OF CHANGE: 20230227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STRATA Skin Sciences, Inc. CENTRAL INDEX KEY: 0001051514 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 133986004 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-51481 FILM NUMBER: 23675205 BUSINESS ADDRESS: STREET 1: 5 WALNUT GROVE DRIVE STREET 2: SUITE 140 CITY: HORSHAM STATE: PA ZIP: 19044 BUSINESS PHONE: 215-619-3200 MAIL ADDRESS: STREET 1: 5 WALNUT GROVE DRIVE STREET 2: SUITE 140 CITY: HORSHAM STATE: PA ZIP: 19044 FORMER COMPANY: FORMER CONFORMED NAME: MELA SCIENCES, INC. /NY DATE OF NAME CHANGE: 20100504 FORMER COMPANY: FORMER CONFORMED NAME: ELECTRO OPTICAL SCIENCES INC /NY DATE OF NAME CHANGE: 19971216 8-K 1 form_8-k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): February 27, 2023

STRATA Skin Sciences, Inc.
(Exact Name of Registrant as Specified in Its Charter)

000-51481
(Commission File Number)

Delaware
13-3986004
(State or Other Jurisdiction of Incorporation)
(I.R.S. Employer Identification No.)

5 WALNUT GROVE DRIVE, SUITE 140
HORSHAM, Pennsylvania 19044
(Address of principal executive offices, including zip code)

(215) 619-3200
(Registrant’s telephone number, including area code)

NOT APPLICABLE
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
  
Trading
Symbol(s)
  
Name of each exchange on which registered
Common Stock, $0.001 par value per share
SSKN
NASDAQ

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On February 27, 2023 STRATA Skin Sciences, Inc. (the “Company”) received notice from The NASDAQ Stock Market (“Nasdaq”) that, STRATA has regained compliance with the Nasdaq listing requirements as required by Rule 5550(a)(2) regarding the Company’s minimum bid price, and the Company will continue to trade on Nasdaq.

Item 7.01.          Regulation FD Disclosure.

On February 27, 2023, the Company issued a press release in connection with the notice of potential delisting discussed in Item 3.01.

Item 9.01          Financial Statements and Exhibits

(d) Exhibits


SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 STRATA SKIN SCIENCES, INC.
 Date: February 27, 2023
 By:  /s/ Christopher Lesovitz            
 
        Christopher Lesovitz
 
        Chief Financial Officer





- 2 -
 EX-99.1 2 ex_99-1.htm STRATA PRESS RELEASE DATED FEBRUARY 27, 2023


 
Exhibit 99.1
 
 
STRATA Skin Sciences Announces Regaining Compliance with NASDAQ’S Minimum Price Rule
 

HORSHAM, Pa., February 27, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it had been notified by Nasdaq that Strata has regained compliance with the Nasdaq listing requirements regarding minimum bid price, Rule 5550(a)(2).

Robert Moccia, Strata’s Chief Executive Officer, stated,“I am pleased to announce that we have received notification that we have regained full compliance with the Nasdaq listing requirements, and we look forward to our continued focus on growing our business.”

About STRATA Skin Sciences, Inc.
STRATA Skin Sciences is a medical technology company dedicated to developing, commercializing and marketing innovative products for the in-office treatment of various dermatologic conditions such as psoriasis, vitiligo, and acne. Its products include the XTRAC® and Pharos® excimer lasers, VTRAC® lamp systems, and now the TheraClear®X Acne Therapy System.

STRATA is proud to offer these exciting technologies in the U.S. through its unique Partnership Program. STRATA’s popular partnership approach includes a fee per treatment cost structure versus an equipment purchase, installation and use of the device, on-site training for practice personnel, service and maintenance of the equipment, dedicated account and customer service associates, and co-op advertising support to help raise awareness and promote the program within the practice.

Safe Harbor
This press release includes "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to the Company’s plans, objectives, expectations and intentions and may contain words such as “will,” “may,” “seeks,” and “expects,” that suggest future events or trends. These statements, the Company’s ability to launch and sell an acne treatment device and to integrate that device into its product offerings, the Company’s ability to develop, launch and sell products recently acquired or to be developed in the future, the Company’s ability to develop social media marketing campaigns, direct to dermatologist marketing campaigns, and the Company’s ability to build a leading franchise in dermatology and aesthetics, are based on the Company’s current expectations and are inherently subject to significant uncertainties and changes in circumstances. Actual results may differ materially from the Company’s expectations due to financial, economic, business, competitive, market, regulatory, adverse market conditions or supply chain interruptions
 


resulting from the coronavirus and political factors or conditions affecting the Company and the medical device industry in general, future responses to and effects of COVID-19 pandemic and its variants including the distribution and effectiveness of the COVID-19 vaccines, as well as more specific risks and uncertainties set forth in the Company’s SEC reports on Forms 10-Q and 10-K. Given such uncertainties, any or all these forward-looking statements may prove to be incorrect or unreliable. The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not undertake any obligation to update or revise these statements to reflect events or circumstances occurring after the date of this press release. The Company urges investors to carefully review its SEC disclosures available at www.sec.gov and www.strataskinsciences.com.


Investor Contact:
Rich Cockrell
CG Capital
Phone: +1 (404) 736-3838
sskn@cg.capital
 

- 2 -
 EX-101.SCH 3 sskn-20230227.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 sskn-20230227_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 5 sskn-20230227_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Document and Entity Information
Feb. 27, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Feb. 27, 2023
Entity File Number 000-51481
Entity Registrant Name STRATA Skin Sciences, Inc.
Entity Central Index Key 0001051514
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 13-3986004
Entity Address, Address Line One 5 WALNUT GROVE DRIVE
Entity Address, Address Line Two SUITE 140
Entity Address, City or Town HORSHAM
Entity Address, State or Province PA
Entity Address, Postal Zip Code 19044
City Area Code 215
Local Phone Number 619-3200
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol SSKN
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
XML 7 form_8-k_htm.xml IDEA: XBRL DOCUMENT 0001051514 2023-02-27 2023-02-27 false 0001051514 8-K 2023-02-27 STRATA Skin Sciences, Inc. 000-51481 DE 13-3986004 5 WALNUT GROVE DRIVE SUITE 140 HORSHAM PA 19044 215 619-3200 false false false false Common Stock, $0.001 par value per share SSKN NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

-8?20$3;8T.P6BP^0"X99K>]9!:GH_ 0 / ( \ !X;"]W;W)K8F]O:RYX;6R-49:EL@9OTDUL(,BDBN0-2TN'+#4$QJ8:@+W+IGD^R[S!H)>+D6M#V743 M&4K&& 3L@!W".?W.NU:=,.$>'?)WH?NW ZT\!O1X 5OH7*M4Q_-+)+S$P,9M M2XK.%7HR#'9 C.4?>-N)_#3[U"-L]A]&A!1ZE@MAA92XW^CYC6@\@2P/73>TFH=>Y!L/?P&HT=S8\?M_P!4$L#!!0 ( (>" M6U8D'INBK0 /@! : >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.U MD3T.@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E. MGV@4=VZ@MO,D1FL&RF3+[.\ I%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S M9)[NF:*'3^ 5!+ P04 M" "'@EM699!YDAD! #/ P $P %M#;VYT96YT7U1Y<&5S72YX;6RMDTU. MPS 0A:\295LE+BQ8H*8;8 M=< %C3QJK_I-G6M+;,T[:2J 2%85-K'C>O,^> MEZS>CQ&PZ)WUV)0=47P4 E4'3F(=(GBNM"$Y2?R:MB)*M9-;$/?+Y8-0P1-X MJBA[E.O5,[1R;ZEXZ7D;3?!-FI6.5Z*U .EK >MKBRAE#VQH%.JB] MXY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ!'_'G2/)W55D(TAD MIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_ MYHOA/UY_ 5!+ 0(4 Q0 ( (>"6U8'04UB@0 +$ 0 M " 0 !D;V-0&UL4$L! A0#% @ AX);5OO5N5OM M *P( !$ ( !KP &1O8U!R;W!S+V-O&UL4$L! M A0#% @ AX);5IE&PO=V]R:W-H965T&UL4$L! M A0#% @ AX);5I^@&_"Q @ X@P T ( !L0P 'AL M+W-T>6QE&PO=V]R:V)O;VLN>&UL4$L! A0# M% @ AX);5B0>FZ*M ^ $ !H ( !XA$ 'AL+U]R M96QS+W=O9(9 0 MSP, !, ( !QQ( %M#;VYT96YT7U1Y<&5S72YX;6Q02P4& 2 D "0 ^ @ $10 end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1 23 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://strataskinsciences.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports form_8-k.htm ex_99-1.htm sskn-20230227.xsd sskn-20230227_lab.xml sskn-20230227_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form_8-k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "form_8-k.htm" ] }, "labelLink": { "local": [ "sskn-20230227_lab.xml" ] }, "presentationLink": { "local": [ "sskn-20230227_pre.xml" ] }, "schema": { "local": [ "sskn-20230227.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 29, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "sskn", "nsuri": "http://strataskinsciences.com/20230227", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form_8-k.htm", "contextRef": "c20230227to20230227", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://strataskinsciences.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "form_8-k.htm", "contextRef": "c20230227to20230227", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "trueItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://strataskinsciences.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001051514-23-000011-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001051514-23-000011-xbrl.zip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